Yahoo Web Search

Search results

    • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 3 days ago

      Progress in the LIBERATE trial was presented at the American Transplant Congress today London, UK– June 4, 2024 – Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical

    • CNS Pharmaceuticals Announces Reverse Stock Split

      Digital Journal· 3 days ago

      The par value of the common stock will remain unchanged at $0.001 per share after the reverse split, and the number of authorized shares of common stock will remain at 300 ...